Biogen Pharmachem Industries share news, announcements and annual reports
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.25.
30 Oct: open ₹0.25, high ₹0.25, low ₹0.24
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹26 Cr3,446th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 23,53,079
Biogen Pharmachem Industries share news and announcements
511 announcements, routine notices left out, newest first. Page 4 of 11.
Sep 2022
27 Sep · Meeting
5 Sep · Reg. 34 (1) Annual Report.
5 Sep · Meeting
Aug 2022
Jul 2022
28 Jul · Board meeting
Meeting on 3 Aug 2022: quarterly results
Jun 2022
13 Jun · Board meeting
Meeting on 13 Jun 20227 Jun · Rectification In Submission Of Half Yearly Disclosure On Related Party Transactions.
May 2022
25 May · Submission Of Half Yearly Disclosure On Related Party Transactions.
19 May · Board meeting
Meeting on 25 May 2022: audited results
Apr 2022
16 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
4 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of The SEDI Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period From April 1, 2021 To March 31, 2022.
1 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Feb 2022
Jan 2022
25 Jan · Board meeting
Meeting on 12 Feb 2022: quarterly results19 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....1 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Dec 2021
2 Dec · Updation Of Directors/Company Secretary Of The Company
Nov 2021
22 Nov · Updation Of Directors/Company Secretary Of The Company
13 Nov · Submission Of Half Yearly Disclosure On Related Party Transactions.
Oct 2021
28 Oct · Board meeting
Meeting on 13 Nov 2021: quarterly results20 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....19 Oct · Update In CIN No. Of Company On BSE PORTAL
1 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Sep 2021
20 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2021
27 Aug · Reg. 34 (1) Annual Report
27 Aug · Meeting
4 Aug · Board meeting
Meeting on 13 Aug 2021: quarterly results
Jul 2021
17 Jul · Updation Of Directors/Company Secretary Of The Company
9 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....1 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 6 6 0
Jun 2021